Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-09-21Clinical Trial Update: Enriched-CRT 2017: Advanced Gastric Cancer With LN+ and LVI+, Chemotherapy vs. Chemoradiotherapy [Phase 3]
Phase 3 trial comparing chemotherapy versus chemoradiotherapy in advanced gastric cancer with lymph node involvement and lymphovascular inva…
-
CLINICAL_TRIALS trial_result · 2018-09-14Clinical Trial Update: Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer [Phase 2]
Phase 2 trial evaluating combination chemotherapy plus interferon alfa followed by filgrastim in gastrointestinal tract cancers, completed.
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: Preoperative Dose-dense Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel to Treat Patients With Locally Gastric Cancer [Phase 2]
A Phase 2 trial of preoperative dose-dense chemotherapy with weekly cisplatin, epirubicin and paclitaxel for locally advanced gastric cancer…
-
CLINICAL_TRIALS trial_result · 2018-07-19Clinical Trial Update: Study of S-1 Plus DC-CIK for Patients With Advanced Gastric Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating S-1 plus DC-CIK cell therapy for advanced gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer [Phase 3]
Phase 3 trial evaluating chemotherapy and radiation therapy after surgery for esophageal or gastric cancer has completed with results posted…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: Herzuma-capecitabine/Cisplatin for Gastric Cancer [Phase 2]
Phase 2 clinical trial evaluating Herzuma (trastuzumab) with capecitabine and cisplatin for HER-2 positive gastric cancer, including metasta…
-
CLINICAL_TRIALS trial_result · 2018-07-16Clinical Trial Update: Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Stomach Cancer [Phase 2]
This Phase 2 study evaluated the combination of capecitabine and oxaliplatin in patients with locally advanced, unresectable, or metastatic …
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Olanzapine Improves the Chemotherapy Tolerance of Advanced Gastric Cancer [Phase 2]
A Phase 2 update suggests that olanzapine may improve chemotherapy tolerance in advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction [Phase 1]
This Phase 1 trial evaluates a multimodal approach using oxaliplatin, fluorouracil, and erlotinib with pre-surgical radiation, followed by a…
-
CLINICAL_TRIALS trial_result · 2018-06-21Clinical Trial Update: Validation of MMS Test for Cancer Monitoring
Clinical trial validating the MMS Test for cancer monitoring has been terminated across multiple indications.
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: An Observational Study of Herceptin (Trastuzumab) in Patients With HER2-positive Advanced Gastric Cancer
This document reports results from an observational study assessing Herceptin (trastuzumab) in patients with HER2-positive advanced gastric …
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and Stomach [NA]
A terminated clinical trial evaluating molecularly tailored therapy for metastatic esophageal and gastric cancer; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: Apatinib Combined With Capecitabine Second-line Treatment of Advanced Gastric Cancer: a Single-arm Exploratory Clinical Pilot Trial
A single-arm exploratory trial evaluating the combination of apatinib and capecitabine as second-line therapy for advanced gastric cancer, w…
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: E. Coli Nissle in Oncology [Phase 3]
Phase 3 clinical trial update for Escherichia coli Nissle 1917 in gastric and colorectal cancer; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2018-05-08Clinical Trial Update: FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer [Phase 2]
Phase 2 trial evaluating FOLFOX with or without Ziv-Aflibercept in esophageal and gastric cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-05-07Clinical Trial Update: A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers [Phase 2]
Phase 2 clinical trial evaluating tasquinimod in advanced/metastatic hepatocellular, ovarian, renal cell, and gastric cancers has been compl…
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: Enhanced Recovery After Surgery Program for Gastric Cancer: a Multi-center Study [NA]
This is a multi-center clinical trial evaluating an Enhanced Recovery After Surgery program for gastric cancer; the trial status is listed a…
-
CLINICAL_TRIALS trial_result · 2018-04-27Clinical Trial Update: A Study of SC-007 in Subjects With Advanced Cancer [Phase 1]
Phase 1 study of SC-007 in patients with advanced cancer sponsored by AbbVie has been terminated, including colorectal cancer and gastric ca…
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric Cancer [Phase 2]
A Phase 2 clinical trial of cabazitaxel in previously treated patients with advanced or metastatic gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Apatinib Plus Docetaxel Versus Docetaxel as Second-line Treatment in Advanced Gastric Cancer (AHEAD-301) [Phase 2]
Phase 2 clinical trial AHEAD-301 compares apatinib plus docetaxel with docetaxel alone as second-line therapy for advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2018-04-11Clinical Trial Update: Screening for Gastric Cancer in High-risk Population
This clinical trial update notes the completion of a study evaluating screening for gastric cancer in individuals at high risk.
-
CLINICAL_TRIALS trial_result · 2018-04-10Clinical Trial Update: Premedication With Simethicone or Simethicone Plus N-acetylcysteine in Improving Visibility During Upper Endoscopy [Phase 4]
Phase 4 clinical trial update examining premedication with simethicone alone or with N-acetylcysteine to improve visualization during upper …
-
CLINICAL_TRIALS trial_result · 2018-04-04Clinical Trial Update: The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding [Phase 3]
Phase 3 trial evaluating whether proton pump inhibitors can prevent bleeding in gastric cancer patients. The study status is TERMINATED.
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: Folfiri as Third Line of Treatment
Clinical trial evaluating the FOLFIRI regimen as a third-line treatment for gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-02Clinical Trial Update: Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies [Phase 2]
A Phase 2 study evaluating ceritinib in ALK- and ROS1-activated gastrointestinal cancers has been terminated.